Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China · Delayed Price · Currency is CNY 245.71
+4.94 (2.05%)
At close: Oct 30, 2026
SHA:688506 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4,514 | 5,177 | 3,220 | 403.96 | 1,005 | 154.22 |
Short-Term Investments | - | 2,504 | 2,533 | - | - | - |
Trading Asset Securities | 1,917 | 2,159 | - | - | - | - |
Cash & Short-Term Investments | 6,432 | 9,840 | 5,753 | 403.96 | 1,005 | 154.22 |
Cash Growth | 4.46% | 71.04% | 1324.16% | -59.79% | 551.49% | -36.99% |
Accounts Receivable | 1,778 | 100.35 | 138.71 | 137.85 | 267.92 | 134.95 |
Other Receivables | 16.68 | 19.4 | 34.33 | 3.9 | 5.14 | 2.95 |
Receivables | 1,795 | 119.75 | 173.05 | 141.75 | 273.06 | 137.9 |
Inventory | 173.28 | 146.31 | 162.19 | 140.91 | 101.33 | 82.33 |
Other Current Assets | 3,199 | 384.42 | 218.87 | 89.2 | 47.22 | 49.36 |
Total Current Assets | 11,599 | 10,491 | 6,307 | 775.82 | 1,426 | 423.81 |
Property, Plant & Equipment | 1,211 | 816.31 | 573.09 | 534.79 | 420.26 | 404.98 |
Long-Term Investments | 23.23 | - | - | - | - | - |
Other Intangible Assets | 48.38 | 30.3 | 26.68 | 28 | 29.53 | 31.16 |
Long-Term Deferred Tax Assets | 9.9 | 38.21 | 179.2 | 76.18 | 83.23 | 65.8 |
Long-Term Deferred Charges | 348.43 | 30.46 | 18.4 | 1.82 | 1.79 | 1.16 |
Other Long-Term Assets | 135.96 | 41.79 | 32.79 | 8.5 | 30.28 | 24.54 |
Total Assets | 13,375 | 11,448 | 7,137 | 1,425 | 1,991 | 951.46 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 584.83 | 206.83 | 219.25 | 160.17 | 128.85 | 45.96 |
Accrued Expenses | 124.61 | 621.31 | 437.25 | 257.88 | 244.81 | 139.81 |
Short-Term Debt | - | 100.08 | 595.5 | 275.12 | 155.13 | 161.23 |
Current Portion of Long-Term Debt | 1,167 | 841.49 | 235.28 | 174.37 | 30.47 | 0.02 |
Current Portion of Leases | - | 23.9 | 12.46 | 46.13 | 68.82 | 24.23 |
Current Income Taxes Payable | 58.34 | - | 14.13 | 0.01 | 4.96 | 1.54 |
Current Unearned Revenue | 6.06 | 7.31 | 356.13 | 8.67 | 17.42 | 10.78 |
Other Current Liabilities | 415.2 | 137.74 | 109.94 | 131.48 | 86.74 | 87.75 |
Total Current Liabilities | 2,356 | 1,939 | 1,980 | 1,054 | 737.2 | 471.32 |
Long-Term Debt | 5,230 | 2,616 | 1,189 | 183.92 | 239.96 | 50 |
Long-Term Leases | 188.45 | 132.8 | 28.13 | 8.65 | 52.95 | 51.42 |
Long-Term Unearned Revenue | 120.09 | 125.82 | 42.27 | 15.63 | 13.29 | 31.04 |
Long-Term Deferred Tax Liabilities | 6.03 | 4.32 | 1.94 | - | 0.08 | - |
Other Long-Term Liabilities | 9.61 | 7.58 | 9.73 | 11.19 | 14.05 | 15.81 |
Total Liabilities | 7,910 | 4,825 | 3,251 | 1,273 | 1,058 | 619.61 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 412.87 | 412.87 | 401 | 401 | 401 | 360.9 |
Additional Paid-In Capital | 4,659 | 4,659 | 885.84 | 858.69 | 858.55 | 14.17 |
Retained Earnings | 840.02 | 1,545 | 2,599 | -1,109 | -328.45 | -45.98 |
Comprehensive Income & Other | -47.1 | 5.5 | 0.53 | 1.13 | 2.79 | 2.76 |
Total Common Equity | 5,465 | 6,623 | 3,886 | 151.87 | 933.89 | 331.85 |
Shareholders' Equity | 5,465 | 6,623 | 3,886 | 151.87 | 933.89 | 331.85 |
Total Liabilities & Equity | 13,375 | 11,448 | 7,137 | 1,425 | 1,991 | 951.46 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6,585 | 3,714 | 2,061 | 688.19 | 547.33 | 286.91 |
Net Cash (Debt) | -153.5 | 6,126 | 3,692 | -284.23 | 457.41 | -132.69 |
Net Cash Growth | - | 65.91% | - | - | - | - |
Net Cash Per Share | -0.37 | 15.18 | 9.21 | -0.71 | 1.26 | -0.37 |
Filing Date Shares Outstanding | 411.91 | 412.87 | 401 | 401 | 401 | 360.9 |
Total Common Shares Outstanding | 411.91 | 412.87 | 401 | 401 | 401 | 360.9 |
Working Capital | 9,243 | 8,552 | 4,327 | -278.01 | 689.14 | -47.51 |
Book Value Per Share | 13.27 | 16.04 | 9.69 | 0.38 | 2.33 | 0.92 |
Tangible Book Value | 5,417 | 6,592 | 3,859 | 123.88 | 904.36 | 300.69 |
Tangible Book Value Per Share | 13.15 | 15.97 | 9.62 | 0.31 | 2.26 | 0.83 |
Buildings | - | 323.1 | 325.3 | 304.56 | 302.23 | 300.82 |
Machinery | - | 717.87 | 640.12 | 554.25 | 439.83 | 419.75 |
Construction In Progress | - | 115.8 | 35.51 | 81.37 | 67.21 | 18.18 |